National Taiwan University Hospital: Hepatitis trials
The registry lists 59 Hepatitis studies with National Taiwan University Hospital as lead sponsor. 4 are open to participants now and 6 have results posted.
Phase 2 2Phase 3 2Phase 4 22No phase 34(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
- A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular CarcinomaNot yet recruitingNCT05752890
- Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSMRecruitingNCT05751889Not applicable
- A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-InfectionNot yet recruitingNCT05467553Phase 2
- EBR/GZR for HCV-1b Patients Receiving HemodialysisCompletedNCT03420300Phase 4Results posted
- PrOD for Non-Cirrhotic Patients With HCV-1b Receiving HemodialysisCompletedNCT02874066Phase 4Results posted
- The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B VaccinesCompletedNCT00792610Not applicableResults posted
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected PatientsCompletedNCT00495131Phase 4Results posted
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis CCompletedNCT00491244Phase 4Results posted
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose RibavirinCompletedNCT00491179Phase 4Results posted
- Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue TherapyStatus unknownNCT05494528Not applicable
- Disease Loads and Status of TreatmentStatus unknownNCT05264272
- Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
- HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
- eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAsCompletedNCT04047680
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected PatientsCompletedNCT03855176Phase 4
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B VirusStatus unknownNCT03695029Phase 4
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfectionStatus unknownNCT03425994
- Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsCompletedNCT03250910Phase 4
- NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced HepatitisStatus unknownNCT02076685Not applicable
- Hepatitis B Seroepidemiology Among Young AdultsStatus unknownNCT01973582
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug TestStatus unknownNCT01312012Phase 4
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A InfectionCompletedNCT01102296Not applicable
- Health Promotion and Management for Hepatitis B CarriersStatus unknownNCT01065363Not applicable
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis CStatus unknownNCT00980161
- Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II TestCompletedNCT00979979
- Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral LoadTerminatedNCT00977054Phase 4
- Investigation of Hepatitis B and Hepatitis C in TaiwanCompletedNCT00946010
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis BStatus unknownNCT00917761Phase 4
- Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis CCompletedNCT00917358Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRCompletedNCT00532701Phase 4
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency DepartmentStatus unknownNCT00201578
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Antibody Response and Immune Memory 15-18 Years After HBV VaccinationStatus unknownNCT00172328Not applicable
- Studies of Immune Responses in Patients With Chronic Hepatitis BCompletedNCT00155155
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationStatus unknownNCT00147459Not applicable
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4